

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 135.80 | 123.63 | 102.32 | 123.04 | 101.95 |
| Total Expenses | 110.13 | 102.95 | 86.43 | 103.48 | 91.16 |
| Profit Before Tax | 25.67 | 20.68 | 15.89 | 19.56 | 10.79 |
| Profit After Tax | 19.50 | 16.78 | 12.58 | 14.09 | 7.25 |
| Operating Profit After Depreciation | 25.90 | 21.04 | 16.11 | 19.78 | 10.86 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 20.65 | 11.47 | 7.04 | 9.32 | 7.21 |
| Total Non Current Assets | 30.14 | 21.39 | 18.14 | 17.23 | 19.29 |
| Total Current Assets | 192.49 | 160.98 | 149.13 | 138.01 | 121.08 |
| Total Assets | 222.63 | 182.37 | 167.27 | 155.24 | 140.37 |
| Total Shareholder's Fund | 171.43 | 151.91 | 134.58 | 121.73 | 107.64 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 18.32 | 3.65 | 8.90 | 9.94 | -1.71 |
| Net Cash Used In Investing Activities | -12.36 | -13.34 | 2.13 | -15.61 | 5.86 |
| Net Cash Used In Financing Activities | -5.44 | 2.58 | -3.79 | 5.44 | 0.19 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 135.76 | 123.61 | 102.36 | 123.06 | 101.96 |
| Total Expenses | 109.92 | 102.94 | 86.43 | 103.48 | 91.17 |
| Profit Before Tax | 25.84 | 20.67 | 15.93 | 19.58 | 10.79 |
| Profit After Tax | 19.68 | 16.78 | 12.62 | 14.13 | 7.26 |
| Operating Profit After Depreciation | 26.11 | 21.06 | 16.16 | 19.82 | 10.89 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 20.65 | 11.47 | 7.04 | 9.32 | 7.21 |
| Total Non Current Assets | 41.53 | 32.65 | 29.29 | 28.33 | 30.36 |
| Total Current Assets | 191.45 | 159.77 | 148.80 | 136.81 | 119.87 |
| Total Assets | 232.98 | 192.42 | 178.09 | 165.14 | 150.23 |
| Total Shareholder's Fund | 181.80 | 161.97 | 145.11 | 131.64 | 117.52 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 18.39 | 3.70 | 10.20 | 2.20 | -1.47 |
| Net Cash Used In Investing Activities | -12.49 | -13.45 | 1.17 | -15.61 | 5.82 |
| Net Cash Used In Financing Activities | -5.48 | 2.26 | -3.48 | 5.41 | -0.03 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 26.26 | 19.11 | 39.92 | 26.15 | 24.94 |
| Total Expenses | 28.50 | 18.69 | 39.72 | 25.41 | 21.62 |
| Profit Before Tax | 0.12 | 11.76 | 2.08 | 8.90 | 9.65 |
| Profit After Tax | 0.11 | 11.77 | -2.12 | 8.90 | 7.69 |
| Operating Profit after Depreciation | 0.82 | 12.36 | 2.68 | 9.54 | 10.23 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 25.63 | 19.11 | 39.11 | 26.15 | 24.94 |
| Total Expenses | 28.50 | 18.69 | 39.47 | 25.41 | 21.66 |
| Profit Before Tax | 0.10 | 11.78 | 2.25 | 8.89 | 9.60 |
| Profit After Tax | 0.10 | 11.78 | -1.95 | 8.89 | 7.63 |
| Operating Profit after Depreciation | 0.82 | 12.38 | 2.88 | 9.54 | 10.19 |
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
No data available
On 14 November 2025
05 Nov 2025, 03:25 pm
On 29 September 2025
15 Sep 2025, 10:44 am
On 13 August 2025
02 Aug 2025, 02:10 pm
On 28 May 2025
19 May 2025, 12:01 pm
On 13 February 2025
04 Feb 2025, 04:36 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.